Literature DB >> 16088239

Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.

Teiko Yamamoto1, Koichiro Hitani, Yukihiro Sato, Hidetoshi Yamashita, Shinobu Takeuchi.   

Abstract

PURPOSE: To compare the efficacy of surgically removing or not removing the internal limiting membrane (ILM) during pars plana vitrectomy on the visual acuity and retinal thickness in eyes with diabetic macular edema.
METHODS: A prospective, case-control study was carried out on 30 eyes of 29 patients undergoing pars plana vitrectomy for diabetic macular edema. Fifteen eyes underwent pars plana vitrectomy with ILM removal and 15 eyes without ILM removal.
RESULTS: In 7 of 15 eyes (47%) in the ILM-removed group, the visual acuity improved by 0.2 or more log of the minimum angle of resolution (log MAR) units and remained unchanged in 8 eyes (53%). In the ILM-preserved group, the final visual acuity improved in 9 of 15 eyes (60%) and remained unchanged in 6 eyes (40%). The difference in visual acuity between the two groups after 11 months the surgery was not significant (Fisher's exact test, p=0.4938). In the ILM-removed group, the final retinal thickness decreased by more than 20% of the preoperative retinal thickness in 12 of 15 eyes (80%), remained unchanged in 2 of 15 eyes (13%), and increased in 1 of 15 eyes (7%). In the ILM-preserved group, the final retinal thickness decreased in 13 of 15 eyes (87%) and remained unchanged in 2 of 15 eyes (23%). The differences in the changes in the retinal thickness between the two groups were not statistically significant (Fisher's exact test, p=0.5945).
CONCLUSION: Vitrectomy in eyes with diabetic macular edema without ILM removal was as effective in reducing the retinal thickness and improving the visual acuity as eyes with ILM removal. We conclude that ILM need not be removed to treat eyes with diabetic macular edema. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16088239     DOI: 10.1159/000085729

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  17 in total

1.  Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema.

Authors:  Sachi Abe; Teiko Yamamoto; Yoshiko Kashiwagi; Eriko Kirii; Sakiko Goto; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2013-10-11       Impact factor: 2.447

2.  Association between cystoid spaces on indocyanine green hyperfluorescence and optical coherence tomography after vitrectomy for diabetic macular oedema.

Authors:  S Yoshitake; T Murakami; A Uji; K Ogino; T Horii; M Hata; S Arichika; K Nishijima; N Yoshimura
Journal:  Eye (Lond)       Date:  2014-01-24       Impact factor: 3.775

3.  Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a Meta-analysis.

Authors:  Xin-Ying Hu; Huan Liu; Li-Na Wang; Yu-Zhi Ding; Jie Luan
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

4.  Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema.

Authors:  Mehmet Bahadir; Aylin Ertan; Ozgür Mertoğlu
Journal:  Int Ophthalmol       Date:  2006-06-19       Impact factor: 2.031

5.  Comparison of surgical procedures for vitreous surgery in diabetic macular edema.

Authors:  Tomoaki Shiba; Yumi Kamura; Fumihiko Yagi; Yukihiro Sato
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

6.  Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.

Authors:  Minhee Cho; Donald J D'Amico
Journal:  Clin Ophthalmol       Date:  2012-07-06

7.  Pars plana vitrectomy with internal limiting membrane peeling for refractory diffuse diabetic macular edema.

Authors:  Mohammad-Hossein Dehghan; Masoud Salehipour; Jalil Naghib; Mahnaz Babaeian; Saeed Karimi; Mehdi Yaseri
Journal:  J Ophthalmic Vis Res       Date:  2010-07

Review 8.  Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema.

Authors:  Shigeo Yoshida; Tomoaki Murakami; Miho Nozaki; Kiyoshi Suzuma; Takayuki Baba; Takao Hirano; Osamu Sawada; Masahiko Sugimoto; Yoshihiro Takamura; Eiko Tsuiki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-30       Impact factor: 3.117

9.  Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema.

Authors:  Ahmed M Saeed
Journal:  Clin Ophthalmol       Date:  2013-02-14

10.  Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome.

Authors:  Su Jeong Song; Joon Hong Sohn; Kyu Hyung Park
Journal:  Korean J Ophthalmol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.